Covid-19 and Diabetes, volume II

184.7K

views

258

authors

31

articles

Covid-19 and Diabetes, volume II

184.7K

views

258

authors

31

articles

Editorial

16 January 2023

Editorial: COVID-19 and diabetes, volume II

Hamad Ali

,

Mohamed Abu-Farha

and

Susanna Hofmann

2,660 views

2 citations

Editors

3

Susanna Hofmann

Helmholtz Center München, Helmholtz Association of German Research Centres (HZ)

Mohamed Abu-Farha

Department of Biochemistry and Molecular Biology, Dasman Diabetes Institute

Health Sciences Center, Kuwait University

Impact

Fetching...

About

Given the success of the previous collection Covid-19 and Diabetes and the continuing advances in the field, we are pleased to announce the launch of Volume II.

People with type 1 or type 2 diabetes mellitus (T2DM) have been highly affected by Covid-19 as they are at a higher risk of developing Covid-19-related complications. The relationship between diabetes mellitus and Covid-19 is complex and multidirectional, nonetheless our efforts to better understand its pathophysiology is evolving at a rapid pace. Individuals with diabetes mellitus are known to be more susceptible to contracting severe Covid-19 and SARS-CoV-2 infection. However, there is also evidence that Covid-19 may influence the pathophysiology of diabetes, affecting blood glucose control not only in those already pre-disposed or living with diabetes but also in those without the disease.

Given the global burden of diabetes and the pandemic course of SARS-CoV-2, more research into the relationship between Covid-19 and diabetes mellitus is vital if we are to effectively treat and understand these diseases in an interconnected manner. We therefore welcome original research and review papers contributing to novel information on the relationship between Covid-19 and diabetes, new-onset diabetes, and severe metabolic complications of preexisting diabetes including kidney disease as well as cardiovascular diseases.

*For articles relating to other aspects of Covid-19 and endocrine research, please see our related Research Topics
Endocrinology and COVID-19: A Cross-Disciplinary Topic Vol. 2
Endocrinology and COVID-19: A Cross-Disciplinary Topic
Covid-19 and Pituitary Endocrinology
Long COVID and Diabetes
Covid-19 and Obesity
The Thyroid and Covid-19
New Drugs for treating COVID-19 Cancer Patients
Musculoskeletal Diseases in COVID-19 Epidemic-19

Given the success of the previous collection Covid-19 and Diabetes and the continuing advances in the field, we are pleased to announce the launch of Volume II.

People with type 1 or type 2 diabetes mellitus (T2DM) have been highly affected by Covid-19 as they are at a higher risk of developing Covid-19-related complications. The relationship between diabetes mellitus and Covid-19 is complex and multidirectional, nonetheless our efforts to better understand its pathophysiology is evolving at a rapid pace. Individuals with diabetes mellitus are known to be more susceptible to contracting severe Covid-19 and SARS-CoV-2 infection. However, there is also evidence that Covid-19 may influence the pathophysiology of diabetes, affecting blood glucose control not only in those already pre-disposed or living with diabetes but also in those without the disease.

Given the global burden of diabetes and the pandemic course of SARS-CoV-2, more research into the relationship between Covid-19 and diabetes mellitus is vital if we are to effectively treat and understand these diseases in an interconnected manner. We therefore welcome original research and review papers contributing to novel information on the relationship between Covid-19 and diabetes, new-onset diabetes, and severe metabolic complications of preexisting diabetes including kidney disease as well as cardiovascular diseases.

*For articles relating to other aspects of Covid-19 and endocrine research, please see our related Research Topics
Endocrinology and COVID-19: A Cross-Disciplinary Topic Vol. 2
Endocrinology and COVID-19: A Cross-Disciplinary Topic
Covid-19 and Pituitary Endocrinology
Long COVID and Diabetes
Covid-19 and Obesity
The Thyroid and Covid-19
New Drugs for treating COVID-19 Cancer Patients
Musculoskeletal Diseases in COVID-19 Epidemic-19

Download ebook

Share

Editors

Susanna Hofmann

Helmholtz Center München, Helmholtz Association of German Research Centres (HZ)

Mohamed Abu-Farha

Department of Biochemistry and Molecular Biology, Dasman Diabetes Institute

Health Sciences Center, Kuwait University

Impact

184,736 Total views

130,735 Article views

52,713 Article downloads

1,288 Topic views

Published In

Journal Thumbnail

Frontiers in Endocrinology

Clinical Diabetes, Diabetes: Molecular Mechanisms

Journal Thumbnail

Frontiers in Public Health

Clinical Diabetes

Journal Thumbnail

Frontiers in Neuroscience

Clinical Diabetes

Journal Thumbnail

Frontiers in Nutrition

Clinical Diabetes

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Suggest a topic